Company BioInfra Co., Ltd.

A199730

KR7199730003

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
8,810 ^KRW	-2.97%		+4.26%	-27.25%

2023	BioInfra Co., Ltd. agreed to acquire 17.649% stake in CLUPEA, Inc. for KRW 2.7 billion.	CI
2023	BioInfra Co., Ltd. has completed an IPO in the amount of KRW 13.65 billion.	CI

BioInfra Co Ltd is a Korea-based company mainly engaged in the research and development of pharmaceuticals. The Company is also engaged in the manufacture and sale of medical devices. In addition, the Company is engaged in the research and development of drugs, non-clinical and clinical trials, health functional foods and others.

KRW in Million	2022	Weight	2023	Weight	Delta
Clinical Trials and New Drug Specimen Analysis 100.0 %	35,427	100.0 %	30,129	100.0 %	-14.96%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	35,427	100.0 %	30,129	100.0 %	-14.96%

Managers	Title	Age	Since
Sang-Deuk Lee CEO	Chief Executive Officer	-	-

Members of the board	Title	Age	Since
Sang-Deuk Lee CEO	Chief Executive Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	4,864,367	2,494,908 ( 51.29 %)	0	51.29 %

Name	Equities	%	Valuation
Sang-Deuk Lee 42.45 %	2,064,849	42.45 %	13 M ₩
Jang-Hyun Kang 6.262 %	304,610	6.262 %	2 M ₩
Kwang-gyu Lim 4.535 %	220,599	4.535 %	1 M ₩
ON Venture Investment Corp. Co., Ltd. 4.523 %	220,000	4.523 %	1 M ₩
Eun-ju Kim 1.222 %	59,453	1.222 %	381 812 ₩
Min-sung Kim 1.222 %	59,453	1.222 %	381 812 ₩
Da-eun Kim 0.9512 %	46,270	0.9512 %	297 150 ₩
Kwang-Gyu Park 0.6167 %	30,000	0.6167 %	192 662 ₩
Mi-kyung Lim 0.4840 %	23,545	0.4840 %	151 208 ₩
Kyu Sang Hwang 0.4625 %	22,500	0.4625 %	144 497 ₩

Bioinfra Co., Ltd.

3-7 Floor, Gyeonggi Bio Center 147 Gwanggyo-ro

16229, Suwon

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
BIOINFRA CO., LTD.	-27.25%	30.75M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B
PFIZER, INC.	+0.45%	164B

Other Pharmaceuticals